Xitao Chen
About
In The Last Decade
Xitao Chen
18 papers receiving 603 citations
Peers
Comparison fields: 5 of 81
- Molecular Biology 231
- Materials Chemistry 229
- Cancer Research 154
- Organic Chemistry 121
- Renewable Energy, Sustainability and the Environment 69
Countries citing papers authored by Xitao Chen
This map shows the geographic impact of Xitao Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xitao Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xitao Chen more than expected).
Fields of papers citing papers by Xitao Chen
This network shows the impact of papers produced by Xitao Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xitao Chen. The network helps show where Xitao Chen may publish in the future.
Co-authorship network of co-authors of Xitao Chen
This figure shows the co-authorship network connecting the top 25 collaborators of Xitao Chen. A scholar is included among the top collaborators of Xitao Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xitao Chen. Xitao Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 5 | |
| 5 | 1 | |
| 6 | 20 | |
| 7 | 16 | |
| 8 | 4 | |
| 9 | 37 | |
| 10 | 139 | |
| 11 | 16 | |
| 12 | 129 | |
| 13 | 127 | |
| 14 | 49 | |
| 15 | 47 | |
| 16 | [Effect of targeting treatment of mitomycin C immunoconjugate on stomach neoplasm]. | 1 |
| 17 | Enhanced antitumor activity of daunomycin conjugated with antigastric cancer monoclonal antibody MGb2. | 5 |
| 18 | Specific targeting of mitomycin C to tumors by anti-gastric cancer monoclonal antibody. | 3 |
| 19 | 6 | |
| 20 | Targeted anti-tumor agents and their cytotoxicity on gastric cancer cells in vitro. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.